Peter Dans

Chief Financial Officer

Peter Dans brings over 25 years of diverse finance experience to Synaptive. For four years, Peter was CFO of Nordion Inc., a health sciences company that was listed on the TSX and NYSE prior to its sale to Sterigenics. Peter has also held CFO roles at Therapure Biopharma and LG-Nortel, and has lived and worked in the Philippines, Singapore and Korea. Peter holds a MBA and both CPA and P. Eng. designations.

© Synaptive Medical, 2012-2018. All rights reserved.

Use of this webpage is subject to our terms of use and privacy policy. Images and video are for demonstrative purposes only. SYNAPTIVE, the Synaptive logo, BrightMatter, and Bridge are trademarks of Synaptive Medical Inc., or its subsidiaries. Patents Pending. Please contact Synaptive Medical for information on regulatory clearance status of our products in your jurisdiction.

Close Menu